India has told the WHO that samples taken from Maiden Pharma company, whose products were linked to deaths of children in Gambia, have been found to comply with required specifications
In letter to WHO, India's drugs controller general says tests on samples of Maiden Pharma's products"have been found to be complying with specifications" and showed no contamination with ethylene glycol and diethylene glycol.
India has told the World Health Organization that samples taken from Indian pharmaceutical company Maiden Pharma, whose products were linked to the deaths of children in Gambia, have been found to comply with the required specifications. In a letter to the WHO dated December 13, India's drugs controller general, V.G. Somani, said that tests on samples of Maiden Pharma's products "have been found to be complying with specifications" and showed the samples were not contaminated with ethylene glycol and diethylene glycol.The WHO did not immediately respond to a request for comment.
Argentina Últimas Noticias, Argentina Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
Turkish unmanned fighter jet Kizilelma makes maiden flightBayraktar Kizilelma, National Unmanned Combat Aerial Vehicle System developed by Baykar Technologies, has finally flown, the Chief Technology Officer Selcuk Bayraktar says
Leer más »
8 Sustainably Made Sofas We Love From Maiden HomeShop its soft velvet, leather, and linen sofas.
Leer más »
U.S. offers full backing to India after China border clashThe Pentagon said it was watching closely, after both Beijing and New Delhi blamed the other side's troops for triggering a skirmish.
Leer más »
How the world's largest solar farm sprung from a desert in IndiaSince construction began in 2015, Bhadla Solar Park has slowly grown to cover an enormous 5,700-hectare desert site with solar panels. And today it generates enough electricity to power 4.5 million homes. Presented by Cummins.
Leer más »
Breakingviews - India bank sale sharpens valuation rivalryIndia’s most highly valued banks may soon have a new challenger. The government is finally selling a controlling stake in one of 13 state-backed lenders. Sumitomo Mitsui Financial , Carlyle and Fairfax Financial may each be eyeing some of the 61% stake on offer in $7 billion IDBI Bank , per reports by The Economic Times and Mint. Bidders will be betting private ownership can speed up this turnaround play’s transformation.
Leer más »
India bank sale sharpens valuation rivalryCarlyle, Sumitomo and others may buy stakes in $7 bln state-backed lender IDBI. It’s a turnaround play still lagging rivals on earnings and tech. Wannabe owners are betting private control can close those gaps and its discount to ICICI and HDFC. That’d prompt more privatisations.
Leer más »